openPR Logo
Press release

“Global mRNA Vaccines and Therapeutics Market Set to Grow To $5.5bn by 2024,” according to Visiongain

05-22-2019 03:24 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: visiongain

Your guide to your industry

Your guide to your industry

Visiongain has launched a new pharma report mRNA Vaccines and Therapeutics Market Forecast 2019-2029: Standardized Therapeutic Cancer mRNA Vaccines, Individualized Therapeutic Cancer mRNA Vaccines, Therapeutic Infectious Disease mRNA Vaccines, mRNA Therapeutic for Other Diseases, Bioengineered Vaccine, Gene Transcription, Monoclonal Antibody, Gene Therapy and Cell Therapy.

mRNA-based drugs have emerged as a highly attractive new class of biologics that encodes any protein of interest directly in vivo. The last two decades have been crucial in generating interest in various RNA based technologies. Clinical and preclinical trials in the field have led to positive responses facilitating increasing funding and investment by major pharmaceutical and biopharmaceutical companies. Clinical trials have proven that mRNA vaccines provide long lasting immune responses and are safe in animal and human models.

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on 020 7549 9987

The lead analyst of the report commented “The major drivers supporting the growth of the mRNA Vaccines and Therapeutics Market are rising adoption of personalized medicine for effective treatment, advantages offered by mRNA-based products, and rising funding by pharmaceutical companies and government organizations. Effective and safe delivery remains a major challenge despite the potential of RNA therapy. High cost of development and stringent process of regulatory approvals might also restrain the mRNA vaccines and therapeutics market.”

Download free report sample pages: https://www.visiongain.com/report/mrna-vaccines-and-therapeutics-market-forecast-2019-2029/

Leading companies featured in the report include Argos Therapeutics, Inc., BioNTech AG. CureVac AG, eTheRNA Immunotherapies, ethris GmbH, In-Cell-Art, Moderna Therapeutics, Sangamo Therapeutics, Inc., Tiba Biotech, Translate Bio and Inc.

Related reports:
Global Cancer Immunotherapy Market Forecast 2019-2029
https://www.visiongain.com/report/global-cancer-immunotherapy-market-forecast-2019-2029/

Global Vaccine Contract Manufacturing Market Report 2019-2029
https://www.visiongain.com/report/global-vaccine-contract-manufacturing-market-report-2019-2029/

For more pharma reports, visit our website: https://www.visiongain.com/industries/pharma/

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on 020 7549 9987

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Visiongain Limited
Airport House
Purley Way
Surrey
London
CR0 0XZ
United Kingdom

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release “Global mRNA Vaccines and Therapeutics Market Set to Grow To $5.5bn by 2024,” according to Visiongain here

News-ID: 1749551 • Views: 468

More Releases from visiongain

Newly Published Visiongain Report: Hybrid Powertrain Systems Market Report 2019- …
Forecasts by Vehicle Type (Hybrid Vehicles, Plug-in Hybrid Vehicles), by Component (Engine, Transmission, Electric Motor and Battery, Others) PLUS Regional and Leading National Market Analysis and Profiles of Leading Companies Purchase full report or download free sample pages: https://www.visiongain.com/report/hybrid-powertrain-systems-market-report-2019-2029/ The latest report from business intelligence provider Visiongain offers a comprehensive analysis of the global Hybrid powertrain systems market. Visiongain assesses that this market will generate revenues of $26.8bn in 2019. Now: The rapidly increasing
Newly Published Visiongain Report: Food Cold Chain Market Report 2019-2029
Forecasts by Technology (Blast Freezing, Vapour Compression, Programmable Logic Controller, Evaporating Cooling, Others), by Type (Refrigerated Storage, Refrigerated Transport), by Application Sector (Fruits & Vegetables, Dairy & Frozen Desserts, Fish, Meat & Seafood, Processed Food and Pharmaceutical) and Geography (North America, Latin America, Asia Oceania, Europe and Rest of World). Purchase full report or download free sample pages: https://www.visiongain.com/report/food-cold-chain-market-report-2019-2029/ • Do you need Food Cold Chain market data? • Succinct Food Cold Chain market
Newly Published Visiongain Report: Smart Glass and Smart Window Market Report 20 …
Forecasts by Type (Electrochromic, Polymer Dispersed Liquid Crystal, Suspended Particle Devices) and by Application (Architectural, Automotive, Aircraft, Consumer Electronics and Others) PLUS Profiles of Leading Companies and Regional and Leading National Market Forecasts. Purchase full report or download free sample pages: https://www.visiongain.com/report/smart-glass-and-smart-window-market-report-2019-2029/ The latest report from business intelligence provider Visiongain offers a comprehensive analysis of the global Smart glass and smart windows technology market. Visiongain assesses that this market will generate revenues of
Newly Published Visiongain Report: LATAM Small Scale LNG (SSLNG) Market Forecast …
Forecasts by Capex ($mn) and Capacity (TTPA), by Type (Liquefaction, Regasification, Satellite Stations, Bunkering Facilities for Vessels and Fuelling), by Country for the Latin American Region. Plus, Profiles of Major Companies. Purchase full report or download free sample pages: https://www.visiongain.com/report/latam-small-scale-lng-sslng-market-forecast-2019-2029/ Small Scale LNG is used to supply small or isolated demand centres not connected to pipeline infrastructure, small scale LNG infrastructure is now increasingly deployed to cater to the growing demand for LNG

All 5 Releases


More Releases for RNA

RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led